A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)

Detalles Bibliográficos
Autores principales: Izzo, I, Albini, L, Calabresi, A, Motta, D, Bellagamba, R, Fezza, R, Narciso, P, Sighinolfi, L, Maggi, P, Focà, E, Mendeni, M, Manili, L, Magoni, M, Carosi, G, Quiros-Roldan, E, Torti, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113092/
http://dx.doi.org/10.1186/1758-2652-13-S4-P85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113092/
http://dx.doi.org/10.1186/1758-2652-13-S4-P85

Ejemplares similares